Cecilia Rosada

2.0k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

Cecilia Rosada is a scholar working on Immunology, Molecular Biology and Dermatology. According to data from OpenAlex, Cecilia Rosada has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Molecular Biology and 8 papers in Dermatology. Recurrent topics in Cecilia Rosada's work include Psoriasis: Treatment and Pathogenesis (9 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (4 papers). Cecilia Rosada is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (9 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (4 papers). Cecilia Rosada collaborates with scholars based in Denmark, United States and China. Cecilia Rosada's co-authors include Karin Stenderup, Moustapha Kassem, Thomas G. Jensen, Janne L. Simonsen, Nedime Serakıncı, Suresh I. S. Rattan, J. Justesen, J. Thomas August, J. Justesen and Søren Kamp and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Biotechnology and Annals of the New York Academy of Sciences.

In The Last Decade

Cecilia Rosada

31 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells

2002 677 citations Janne L. Simonsen, Cecilia Rosada et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cecilia Rosada Denmark	16	709	493	355	282	266	31	1.6k
Monika Dohse United States	7	1.3k 1.8×	959 1.9×	910 2.6×	265 0.9×	226 0.8×	8	2.6k
Bernard Martin United States	11	476 0.7×	159 0.3×	137 0.4×	140 0.5×	203 0.8×	12	1.1k
Richard J. Bauer Germany	22	727 1.0×	196 0.4×	220 0.6×	202 0.7×	389 1.5×	55	1.6k
Jérôme Amiaud France	24	685 1.0×	210 0.4×	187 0.5×	496 1.8×	462 1.7×	48	1.8k
Qilong Lu United States	22	1.4k 2.0×	191 0.4×	263 0.7×	158 0.6×	544 2.0×	45	2.1k
Nicolas O. Fortunel France	20	733 1.0×	237 0.5×	72 0.2×	223 0.8×	298 1.1×	42	1.5k
Jacob M. Waugh United States	19	658 0.9×	212 0.4×	560 1.6×	155 0.5×	91 0.3×	33	1.6k
Ulla Impola Finland	20	585 0.8×	215 0.4×	221 0.6×	161 0.6×	292 1.1×	29	1.4k
Barry Grimes United States	14	1.5k 2.1×	396 0.8×	158 0.4×	537 1.9×	754 2.8×	17	2.5k
Marta Serafini Italy	23	675 1.0×	509 1.0×	284 0.8×	315 1.1×	476 1.8×	67	1.8k

Countries citing papers authored by Cecilia Rosada

Since Specialization

Citations

This map shows the geographic impact of Cecilia Rosada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Rosada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Rosada more than expected).

Fields of papers citing papers by Cecilia Rosada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Rosada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Rosada. The network helps show where Cecilia Rosada may publish in the future.

Co-authorship network of co-authors of Cecilia Rosada

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Rosada. A scholar is included among the top collaborators of Cecilia Rosada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Rosada. Cecilia Rosada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosada, Cecilia, et al.. (2023). Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases. Life Science Alliance. 6(5). e202201425–e202201425. 1 indexed citations

Christiansen, Helle, et al.. (2015). Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo. SHILAP Revista de lepidopterología. 7(3). 6246–6246. 9 indexed citations

Stenderup, Karin, Cecilia Rosada, Kurt Shanebeck, et al.. (2015). AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model. Protein Engineering Design and Selection. 28(10). 467–480. 14 indexed citations

Stenderup, Karin, Cecilia Rosada, Bruno Gavillet, G. Vuagniaux, & T Dam. (2014). Debio 0932, A New Oral Hsp90 Inhibitor, Alleviates Psoriasis in a Xenograft Transplantation Model. Acta Dermato Venereologica. 94(6). 672–676. 30 indexed citations

Staunstrup, Nicklas Heine, Rasmus O. Bak, Yujia Cai, et al.. (2013). A lentiviral vector‐based genetic sensor system for comparative analysis of permeability and activity of vitamin D3 analogues in xenotransplanted human skin. Experimental Dermatology. 22(3). 178–183. 4 indexed citations

Stenderup, Karin, et al.. (2013). Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin diseases.. PubMed. 12(10). 1156–62. 2 indexed citations

Hauge, Ellen‐Margrethe, et al.. (2012). Topical valrubicin application reduces skin inflammation in murine models. British Journal of Dermatology. 167(2). 288–295. 5 indexed citations

Kamp, Søren, Anne‐Marie Kanstrup Fiehn, Karin Stenderup, et al.. (2011). Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. British Journal of Dermatology. 164(5). 1017–1022. 94 indexed citations

Gesser, Borbala, Mads Kirchheiner Rasmussen, Line Raaby, et al.. (2011). Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression. Inflammation Research. 60(7). 643–653. 35 indexed citations

10.

Bak, Rasmus O., Karin Stenderup, Cecilia Rosada, et al.. (2011). Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin. BMC Dermatology. 11(1). 5–5. 20 indexed citations

11.

Andersen, Søren, et al.. (2010). Topical application of valrubicin has a beneficial effect on developing skin tumors. Carcinogenesis. 31(8). 1483–1490. 12 indexed citations

12.

Jakobsen, Maria, Karin Stenderup, Cecilia Rosada, et al.. (2009). Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model. Molecular Therapy. 17(10). 1743–1753. 62 indexed citations

13.

Kamp, Søren, Gregor B. E. Jemec, Kåre Kemp, et al.. (2009). Application of stereology to dermatological research. Experimental Dermatology. 18(12). 1001–1009. 13 indexed citations

14.

Rosada, Cecilia, et al.. (2009). Valrubicin in a Topical Formulation Treats Psoriasis in a Xenograft Transplantation Model. Journal of Investigative Dermatology. 130(2). 455–463. 11 indexed citations

15.

Stenderup, Karin, Cecilia Rosada, Anne Worsaae, et al.. (2009). Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model. British Journal of Dermatology. 160(2). 284–296. 55 indexed citations

16.

Stenderup, Karin, Cecilia Rosada, Anne Worsaae, Jes Thorn Clausen, & Tomas Norman Dam. (2007). Interleukin‐20 as a Target in Psoriasis Treatment. Annals of the New York Academy of Sciences. 1110(1). 368–381. 23 indexed citations

17.

Stenderup, Karin, et al.. (2004). Aged Human Bone Marrow Stromal Cells Maintaining Bone Forming Capacity in vivo Evaluated Using an Improved Method of Visualization. Biogerontology. 5(2). 107–118. 49 indexed citations

18.

Simonsen, Janne L., Cecilia Rosada, Nedime Serakıncı, et al.. (2002). Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nature Biotechnology. 20(6). 592–596. 677 indexed citations breakdown →

19.

Martensen, Pia M., Max Søgaard, Henriette N. Buttenschøn, et al.. (2001). The interferon alpha induced protein ISG12 is localized to the nuclear membrane. European Journal of Biochemistry. 268(22). 5947–5954. 39 indexed citations

20.

Kim, Hyunsun A., et al.. (1994). CD44 Expression in Colorectal Adenomas Is an Early Event Occurring Prior to K-ras and p53 Gene Mutation. Archives of Biochemistry and Biophysics. 310(2). 504–507. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact